Search Results 61-70 of 16782 for Selective estrogen receptor modulator

  1. Mayo Clinic Q and A: Genetic abnormalities and cancer risk

    Selective Estrogen Receptor Modulators (SERMS) and Aromatase Inhibitors (AIs) are types of medications that can reduce the risk of developing breast cancer.

  2. Esterified estrogens and methyltestosterone (oral route) - Side effects & dosage - Mayo Clinic

    Esterified estrogens are a man-made mixture of estrogens. Estrogen is a hormone that is produced by the body in greater amounts in females. It is necessary ...

  3. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

    It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This ...

  4. TUESDAY Q & A: Treatment plan should be based on specific type of breast cancer

    This type of cancer is characterized by the presence of estrogen receptors. If a tumor is estrogen receptor (ER) positive, that means the breast cancer cells ...

  5. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    This research trial studies genetic profiles in blood and tumor samples from patients with estrogen receptor positive and HER2 negative breast cancer that has ...

  6. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    RATIONALE: Estrogen can cause the growth of breast cancer cells. ... estrogen the body makes. Everolimus may stop the ... receptor (PR) status, and negative human ...

  7. Conjugated estrogens (intravenous route) - Side effects & uses - Mayo Clinic

    Conjugated estrogens injection is used to treat abnormal bleeding from your uterus caused by hormonal imbalance when your doctor has found no other cause of ...

  8. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

    It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This ...

  9. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by ...

  10. Breast Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this trial is to determine how well estradiol works in treating patients with estrogen receptor beta (ER beta) positive, triple negative breast ...